Olink studies in pharma
Two posters that demonstrate the use of Olink protein biomarker data in pharma applications.
- Pratta et al (Incyte Corporation) "A Biomarker Signature to Predict Complete Response to Itacitinib and Corticosteroids in Acute Graft-Versus-Host Disease".
- Ticau et al (Alnylam Pharmaceuticals) "Neurofilament Light Chain (NfL) as a Potential Biomarker in Hereditary Transthyretin Mediated ( hATTR ) Amyloidosis"